Phase 2 Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to sign and date a consent form agreeing to take part
- People who are willing to follow all study procedures and are available for the full duration of the study
- People who are male or female, aged 65 years or older
- People who can speak and read English and currently live in the United States
- People who have access to an internet-connected device (such as a computer, tablet, or smartphone) and are willing to receive study-related emails
- People who have trouble falling asleep and/or staying asleep at night
- People whose sleep problems (or related daytime tiredness) have been causing significant distress or affecting their social, work, or daily life for the past three months
- People who show some level of cognitive (thinking or memory) difficulty based on a study assessment
- People who have been on a stable medication routine, unless any of those medications are known to cause sleep problems
Who may not be able to join:
- People who are currently receiving psychological treatment for insomnia
- People who have started any psychological or psychiatric treatment within the past three months
- People who have a current diagnosis of Huntington's or Parkinson's disease
- People who are currently being treated for an overactive thyroid (hyperthyroidism)
- People who are currently undergoing chemotherapy
- People who have asthma or breathing concerns that may be affected by night-time treatment
- People whose chronic pain is being managed with opioid medications
- People who have not yet recovered from a brain tumour, brain injury, or brain infection
- People who have epilepsy that has not been under stable treatment for at least three months
- People who have an irregular or inconsistent sleep schedule
- People who use stimulating medications after 5pm, or who have been taking such medications for less than three months
- People who have a psychotic disorder or bipolar disorder
- People who are assessed as being at moderate to high risk of suicide
- People who have had issues with alcohol or drug misuse within the past year
- People who have other untreated sleep disorders, such as obstructive sleep apnea
- People whose study screening indicates severe depression
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Meghan K Mattos, PhD, RN, CNL, University of Virginia
Phone: 434-243-3936
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Insomnia Severity Index
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.